Did you know? You can suggest edits to improve this peptide information.
Overview
What is Melanotan I?
Melanotan I (afamelanotide) is a synthetic analog of α-melanocyte stimulating hormone that selectively targets MC1 receptors to stimulate melanin production. While an FDA-approved implant version (SCENESSE®) exists for rare medical conditions, research-grade injectable Melanotan I is studied for its photoprotective and tanning effects through regular subcutaneous administration.
Key Benefits
Research-grade injectable Melanotan I provides precise dosing control and rapid onset of tanning effects. Unlike the FDA-approved SCENESSE® implant, injectable form allows flexible dosing and can be administered at home. Produces visible tanning within 1-2 weeks with proper UV exposure.
Mechanism of Action
Subcutaneous injection delivers Melanotan I directly into systemic circulation with 100% bioavailability. 30-minute half-life requires multiple daily injections for sustained MC1R activation and melanin production.
Research Indications
Enhanced Tanning Response
Stimulates melanin production allowing deeper, longer-lasting tan with reduced UV exposure requirements
Photoprotection
Increased melanin density provides natural protection against UV damage and reduces sunburn susceptibility
Even Pigmentation
Promotes uniform melanin distribution reducing patchy tanning and providing consistent skin tone
Research Protocols
Disclaimer
These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing
Multiple daily injections needed due to 30-minute half-life. Best results when combined with minimal UV exposure 2-3 hours after injection for enhanced melanin synthesis.
Peptide Interactions
How to Reconstitute
Important
Use BAC water. Light sensitive - store in dark location or wrap vial to protect from light. Refrigerate and use within 30 days.
Allow vial to reach room temperature (15-20 minutes)
Clean vial top with alcohol swab and allow to dry
Calculate required bacteriostatic water volume using the calculator below
Draw calculated volume of bacteriostatic water into syringe
Inject water slowly down the inside wall of the vial (never directly onto powder)
Gently swirl until powder completely dissolves (never shake)
Solution should be clear - discard if cloudy or contains particles
Store reconstituted solution in refrigerator at 2-8°C
Quality Indicators
Third-party laboratory testing
Reputable vendors provide HPLC purity testing and amino acid analysis confirming >98% purity
Proper peptide storage
Lyophilized powder stable at room temperature during shipping, refrigerate upon arrival
Clear reconstitution
Properly reconstituted Melanotan I should be completely clear and colorless without particles
Premixed solutions
Avoid pre-mixed liquid Melanotan I as peptides degrade rapidly in solution without proper preservation
Minimal side effects
High-quality Melanotan I should cause only mild nausea and flushing, not severe reactions
What to Expect
- Days 1-3: Possible mild nausea, facial flushing, reduced appetite
- Days 3-7: Initial skin darkening, increased pigmentation of moles and freckles
- Week 1-2: Noticeable tanning with minimal UV exposure, enhanced tanning response
- Week 2-4: Peak tanning effects, maintained pigmentation with reduced injection frequency
Side Effects & Safety
- Research peptide - not approved for human consumption, sold for research purposes only
- Start with lower doses to assess individual tolerance and response
- Monitor moles and skin changes - perform regular self-examinations
- Use proper sterile injection technique to prevent infections
- Maintain UV protection despite enhanced tanning - still risk of overexposure
References
Safety Profile Assessment (2006)
Comprehensive safety evaluation showing excellent tolerability profile with transient nausea and flushing as primary side effects. No serious adverse events reported.
View Study (opens in new tab) →MT-I Photoprotection Study (2004)
Clinical study demonstrating Melanotan I ability to induce protective tanning with reduced UV exposure requirements. Subjects showed enhanced melanin production and decreased sunburn susceptibility.
View Study (opens in new tab) →Tanning Efficacy Comparison (2003)
Study demonstrating Melanotan I ability to produce visible tanning without UV exposure, though enhanced effects observed when combined with minimal UV exposure.
View Study (opens in new tab) →Quick Start Guide
Community Poll
Question 1 of 10
What is your experience with this compound?
Poll Results
Loading results...
Community Insights
Self-reported by Nootpedia users. Not clinical evidence. Health changes reflect all users, including those taking multiple compounds.
Was this helpful?
Your feedback helps us improve Nootpedia